Millendo Gets European Foothold With Alizé Acquisition

 
• By Kevin Grogan

The US company is getting hold of livoletide, the French firm's late-stage ready compound for reducing hyperphagia, or insatiable hunger, in patients suffering from the rare genetic disease Prader-Willi Syndrome.

EU flags
Welcome to Europe: Millendo of the US has acquired France's Alizé • Source: Shutterstock

More from Business

More from Scrip